• RACHNA SHASHIKANT JADHAV Institute of Chemical Technology (ICT), Mumbai, Maharashtra, India.
  • NIRANJAN NANDKUMAR PATIL Department of Microbiology, Bhavan’s College (Andheri), Mumbai, Maharashtra, India.
  • BHASKAR SAHA Department of Life Science and Biochemistry, St. Xavier’s College, Mumbai, Maharashtra, India.



Alzheimer’s, Parkinson’s, brain injury, neuroplasticity, free radical scavengers, subarachnoid hemorrhage, synaptogenesis, hypoxia.


With an increasing number of neurodegenerative diseases and brain injuries, the focus of the research using synthetic and herbal medicines with an objective to treat the existing problems in neuroscience is ever-increasing. The availability of natural resources, knowledge about ancient herbs, and the mechanisms underlying neurodegenerative disorders and brain injuries is essential to developing herbal supplements with the potential to treat brain diseases and injuries. Despite the variety of synthetically manufactured drugs for brain health, the need for herbal and natural supplements is ever-rising due to the adverse long-term side effects of synthetic drugs. Ginkgo biloba — an Asian plant that is known to possess various neuroprotective properties — has been used as a medicine, even before 1505 AD. G. biloba extract EGB761 has been known to treat and manage impaired nervous system disorders. The current review discusses the neuroprotective properties of G. biloba and its repair mechanisms against subarachnoid hemorrhage, central nervous system (CNS) injuries like traumatic brain injury, ischemic brain injury, early brain injury, spinal cord injury, hypoxia, neuronal apoptosis, neurodegenerative diseases like Alzheimer’s, Parkinson’s, neuroplasticity, neurogenesis, synaptogenesis and its free radical scavenging activity, and neuroleptic properties for a nutritional approach to manage neurodegenerative disorders and CNS injuries.


Kennedy DO, Wake G, Savelev S, Tildesley NT, Perry EK, Wesnes KA, et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology 2003;28:1871-81.

Kumar MH, Gupta YK. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer’s disease in rats. Clin Exp Pharmacol Physiol 2003;30:336-42.

Jeyasri R, Muthuramalingam P, Suba V, Ramesh M, Chen JT. Bacopa monnieri and their bioactive compounds inferred multi-target treatment strategy for neurological diseases: A cheminformatics and system pharmacology approach. Biomolecules 2020;10:536.

Yang L, Hao J, Zhang J, Xia W, Dong X, Hu X, et al. Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin. J Pharmacol 2009;61:375-80.

Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer’s disease: From ethnobotany to phytotherapy. J Pharmacol 1999;51:527-34.

Gong W, Chen C, Dobeš C, Fu C, Koch MA. Phylo-geography of a living fossil: Pleistocene glaciations forced Ginkgo biloba L. (Ginkgoaceae) into two refuge areas in China with limited subsequent postglacial expansion. Mol Phylogenet Evol 2008;48:1094-105.

Ihl R. Effects of Ginkgo biloba extract EGB761® in dementia with neuropsychiatric features: Review of recently completed randomised, controlled trials. Int J Psychiatry Clin Pract 2013;17(Suppl 1):8-14.

Baek SH, Lee JH, Ko J, Lee H, Nam D, Lee SG, et al. Ginkgetin blocks constitutive STAT3 activation and induces apoptosis through induction of SHP-1 and PTEN tyrosine phosphatases. Phytother Res 2016;30:567-76.

Mckenna DJ, Jones K, Hugues K. Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 2001;7:70-90.

Jiang M, Li J, Peng Q, Liu Y, Liu W, Luo C, et al. Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J Neuroinflamm 2014;11:167.

He J, Lin J, Li J, Zhang JH, Sun XM, Zeng CM. Dual effects of Ginkgo biloba leaf extract on human red blood cells. Nordic Soc Pharmacol 2008;104:138-44.

Schneider CM, Pereira JM, Morais LO, Silva AG. O extrato de folhas e sementes do ginkgo, Ginkgo biloba L. (Ginkgoaceae) no tratamento e profilaxia das isquemias. Natureza Online 2007;5:90-5.

Yao LH, Jiang YM, Shi J, Tomás-Barberán FA, Datta N, Singanusong R, et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr 2004;59:113-22.

Usai S, Grazzi L, Bussone G. Gingkolide B as migraine preventive treatment in young age: Results at 1-year follow-up. Neurol Sci 2011;32 Suppl 1:S197-9.

Chung HJ. Evaluation of the biological activity of extracts from star-anise. J Food Sci Nutr 2009;14:195-200.

Wang X, Gong X, Zhang H, Zhu W, Jiang Z, Shi Y, et al. In vitro anti-aging activities of Ginkgo biloba leaf extract and its chemical constituents. Food Sci Technol Camp 2020;40:476-82.

Kim MS, Bang JH, Lee J, Han J, Baik TG, Jeon WK. Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system. Phytomedicine 2016;23:1356-64.

Wan W, Zhang C, Danielsen M, Li Q, Chen W, Chan Y, et al. Egb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse. Exp Gerontol 2016;81:92-100.

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled Phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011;10:618-25.

Yu T, Fan Y, Xu Y, Xu L, Xu G, Cao F, et al. Standardized Ginkgo biloba extract EGB761® attenuates early brain injury following subarachnoid hemorrhage via suppressing neuronal apoptosis through the activation of Akt signaling. Biomed Pharmacother 2018;107:329-37.

Fermino BL, Milanez MC, Freitas GB, Da Silva WC, Pereira RP, Rocha JB, et al. Ginkgo biloba: Phytochemical components and antioxidant activity. Afr J Pharm Pharmacol 2015;9:950-5.

Kotil K, Uyar R, Bilge T, Ton T, Kucukhuseyin C, Koldas M, et al. Investigation of the dose-dependent antivasospasmic effect of Ginkgo biloba extract (EGB761) in experimental subarachnoid hemorrhage. J Clin Neurosci 2008;15:1382-6.

Sung JH, Shah FA, Cho EH, Gim SA, Jeon SJ, Kim KM, et al. Ginkgo biloba extract (EGB761) prevents the ischemic brain injury-induced decrease in parvalbumin expression. Lab Anim Res 2012;28:77-82.

Starkov AA, Chinopoulos C, Fiskum G. Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 2004;36:257-64.

Tulsulkar J, Shah ZA. Ginkgo biloba prevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanisms. Neurochem Int 2013;62:189-97.

Tulsulkar J, Glueck B, Hinds TD Jr., Shah ZA. Ginkgo biloba extract prevents female mice from ischemic brain damage and the mechanism is independent of the HO1/Wnt pathway. Transl Stroke Res 2016;7:120-31.

Amen DG, Wu JC, Taylor D, Willeumier K. Reversing brain damage in former NFL players: Implications for traumatic brain injury and substance abuse rehabilitation. J Psychoactive Drugs 2011;43:1-5.

Li S, Zhang X, Fang Q, Zhou J, Zhang M, Wang H, et al. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: A randomised controlled trial. Stroke Vasc Neurol 2017;2:189-97.

Ginkgo biloba extract and neural regeneration. Neural Regen Res 2012;7:719.

Lacour M, Ez-Zaher L, Raymond J. Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of Ginkgo biloba (EGB761). Pharmacol Biochem Behav 1991;40:367-79.

Gale SD, Hopkins RO. Effects of hypoxia on the brain: Neuroimaging and neuropsychological findings following carbon monoxide poisoning and obstructive sleep apnea. J Int Neuropsychol Soc 2004;10:60-71.

Abdel-Wahab BA, Abd El-Aziz SM. Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats, Phytomedicine 2012;19:444-50.

Oberpichler H, Beck T, Abdel-Rahman MM, Bielenberg GW, Krieglstein J. Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol Res Commun 1998;20:349-63.

Wang C, Wang B. Ginkgo biloba extract attenuates oxidative stress and apoptosis in mouse cochlear neural stem cells. Phytother Res 2016;30:774-80.

Tian X, Zhang L, Wang J, Dai J, Shen S, Yang L, et al. The protective effect of hyperbaric oxygen and Ginkgo biloba extract on Aβ25-35- induced oxidative stress and neuronal apoptosis in rats. Behav Brain Res 2013;242:1-8.

Lebda MA, Sadek KM, Tohamy HG, Abouzed TK, Shukry M, Umezawa M, et al. Potential role of α-lipoic acid and Ginkgo biloba against silver nanoparticles-induced neuronal apoptosis and blood-brain barrier impairments in rats. Life Sci 2018;212:251-60.

Bastianetto S, Zheng WH, Quirion R. The Ginkgo biloba extract (EGB761) protects and rescues hippocampal cells against nitric oxide-induced toxicity. J Neurochem 2000;74:2268-77.

Gerlai R. Alzheimer’s disease: Beta-amyloid hypothesis strengthened! Trends Neurosci 2001;24:199.

Bastianetto S, Ramassamy C, Doré S, Christen Y, Poirier J, Quirion R. The Ginkgo biloba extract (EGB761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 2000;12:1882-90.

Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer’s disease models can be attenuated by Ginkgo biloba extract EGB761. J Alzheimers Dis 2003;5:287-300.

Stockburger C, Eckert S, Eckert GP, Friedland K, Müller WE. Mitochondrial function, dynamics, and permeability transition: A complex love triangle as a possible target for the treatment of brain aging and Alzheimer’s disease. J Alzheimers Dis 2018;64:S455-67.

Tchantchou F, Xu Y, Wu Y, Christen Y, Luo Y. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer’s disease. FASEB J 2007;21:2400-8.

Augustin S, Rimbach G, Augustin K, Schliebs R, Wolffram S, Cermak R. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer’s disease. Arch Biochem Biophys 2009;481:177-82.

Marcilhac A, Dakine N, Bourhim N, Guillaume V, Grino M, Drieu K, et al. Effect of chronic administration of Ginkgo biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat. Life Sci 1998;62:2329-40.

Solfrizzi V, Panza F. Plant-based nutraceutical interventions against cognitive impairment and dementia: Meta-analytic evidence of efficacy of a standardized Ginkgo biloba extract. J Alzheimer’s Dis 2015;43:605-11.

Kanowski S, Herrmann WM, Stephan K, Wierich W, Hoerr R. Proof of efficacy of the Ginkgo biloba special extract EGB761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996;29:47-56.

Silberstein RB, Pipingas A, Song J, Camfield DA, Nathan PJ, Stough C. Examining brain-cognition effects of Ginkgo biloba extract: Brain activation in the left temporal and left prefrontal cortex in an object working memory task. Evid Based Complement Alternat Med 2011;2011:164139.

Abdel-Kader R, Hauptmann S, Keil U, Scherping I, Leuner K, Eckert A, et al. Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacol Res 2007;56:493-502.

Eckert A, Keil U, Scherping I, Haptmann S, Müller WE. Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo Biloba extract EGb 761. Ann N YAcad Sci 2005;1056:474-85.

Tchantchou F, Lacor PN, Cao Z, Lao L, Hou Y, Cui C, et al. Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. J Alzheimers Dis 2009;18:787-98.

Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, et al. Mitochondrial dysfunction: The first domino in brain aging and Alzheimer’s disease? Antioxid Redox Signal 2007;9:1659-76.

Da Silva GG, Zanoni JN, Buttow NC. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol 2011;17:898-905.

Calapai G, Crupi A, Firenzuoli F, Marciano MC, Squadrito F, Inferrera G, et al. Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 2000;67:2673-83.

Kobuchi H, Boy-Lefaix MT, Christen Y, Packer L. Ginkgo biloba extract (EGB761): Inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997;53:897-903.

Alsmadi AM, Tawalbeh LI, Gammoh OS, Shawagfeh MQ, Zalloum W, Ashour A, et al. The effect of Ginkgo biloba and psycho-education on stress, anxiety and fatigue among refugees. Proc Singapore Healthc 2018;27:26-32.

Montes P, Ruiz-Sanchez E, Rojas C, Rojas P. Ginkgo biloba extract 761: A review of basic studies and potential clinical use in psychiatric disorders. CNS Neurol Disord Drug Targets 2015;14:132-49.

Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Kirtas O. The effect of extract of Ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia. Psychiatry Clin Neurosci 2005;59:652-6.



How to Cite




Review Article(s)